James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 1,563 shares at $16.88 ($26K) on 2021-12-28, disclosed to the SEC on 2021-12-30.
Scheduled sale ($26k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |